AMGN

NASDAQ · Biotechnology

Amgen Inc

S&P 500 Nasdaq 100 Dow Jones Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$351.85

+2.85 (+0.82%)

Analyst Consensus

Hold

Analysts

Very High

Coverage

Buy 21 50%

Hold 18 43%

Sell 3 7%

Price Target

Analyst Price Target -45.8% upside

Low Target $141.50

Average Target $190.87

High Target $279.75

Current Price $351.85

Current
$351.85

Target
$190.87

$141.50 $190.87 avg $279.75

Scenario Analysis

Bear Case

$141.50

-59.8%

Low target

Base Case

$190.87

-45.8%

Avg target

Bull Case

$279.75

+-20.5%

High target

Risk/Reward

0.3x

Unfavorable

Price in Context

52-Week High

$391.29

-10.1% from high

52-Week Low

$261.43

+34.6% from low

50-Day SMA

$340.27

+3.4% vs SMA

200-Day SMA

$306.48

+14.8% vs SMA

RSI (14)

67.1

Neutral

Target vs 52W High

$190.87

-51.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+18.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-45.8%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-1.8%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-69.1%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-12.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-28.5%